A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 203 participants.
Also called NCT02853630
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 203 participants
- Sponsor
- India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
- Registry
-
NCT02853630
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT02853630. Randomized; no masking; primary purpose treatment. Start 2013-12 (actual); primary completion 2017-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
- Condition
- TYpe 2 Diabetes Mellitus
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Vildagliptin
- Lead sponsor
- India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
Record details
- Record id
cardio:ct-nct02853630- Content hash
b6b4d4d223206318adb74f5c2ed3f56b7a3d586eecea442c07a5cd52f5ea44e9